Bellemain-Appaix A - Search Results

1

Optimal use of thienopyridines in non-ST-elevation acute coronary syndrome following CURRENT-OASIS 7.

Silvain J, Bellemain-Appaix A, Barthélémy O, Beygui F, Collet JP, Montalescot G. Silvain J, et al. Circ Cardiovasc Interv. 2011 Feb 1;4(1):95-103. doi: 10.1161/CIRCINTERVENTIONS.109.910406. Circ Cardiovasc Interv. 2011. PMID: 21325198 No abstract available.

2

Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD Study.

Cayla G, Silvain J, Barthelemy O, Connor S', Payot L, Bellemain-Appaix A, Beygui F, Aout M, Collet JP, Vicaut E, Montalescot G; ABOARD investigators. Cayla G, et al. Heart. 2011 Jun;97(11):887-91. doi: 10.1136/hrt.2010.220137. Epub 2011 Mar 18. Heart. 2011. PMID: 21421600 Clinical Trial.

3

Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.

Beygui F, Silvain J, Pena A, Bellemain-Appaix A, Collet JP, Drexler H, Bhatt D, Vicaut E, Montalescot G. Beygui F, et al. Am J Cardiol. 2010 Sep 1;106(5):650-8. doi: 10.1016/j.amjcard.2010.04.019. Epub 2010 Jul 23. Am J Cardiol. 2010. PMID: 20723640 Clinical Trial.

4

High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).

Collet JP, Hulot JS, Anzaha G, Pena A, Chastre T, Caron C, Silvain J, Cayla G, Bellemain-Appaix A, Vignalou JB, Galier S, Barthélémy O, Beygui F, Gallois V, Montalescot G; CLOVIS-2 Investigators. Collet JP, et al. JACC Cardiovasc Interv. 2011 Apr;4(4):392-402. doi: 10.1016/j.jcin.2011.03.002. JACC Cardiovasc Interv. 2011. PMID: 21511218 Free article. Clinical Trial.

5

CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients.

Hulot JS, Collet JP, Cayla G, Silvain J, Allanic F, Bellemain-Appaix A, Scott SA, Montalescot G. Hulot JS, et al. Circ Cardiovasc Interv. 2011 Oct 1;4(5):422-8. doi: 10.1161/CIRCINTERVENTIONS.111.963025. Epub 2011 Oct 4. Circ Cardiovasc Interv. 2011. PMID: 21972404 Clinical Trial.

6

Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.

Barthélémy O, Silvain J, Brieger D, Mercadier A, Lancar R, Bellemain-Appaix A, Beygui F, Collet JP, Costagliola D, Montalescot G. Barthélémy O, et al. Catheter Cardiovasc Interv. 2012 Jan 1;79(1):104-12. doi: 10.1002/ccd.23164. Epub 2011 Dec 8. Catheter Cardiovasc Interv. 2012. PMID: 22162411

7

Pretreatment with P2Y12 inhibitors in non-ST-Segment-elevation acute coronary syndrome: an outdated and harmful strategy.

Collet JP, Silvain J, Bellemain-Appaix A, Montalescot G. Collet JP, et al. Circulation. 2014 Nov 18;130(21):1904-14; discussion 1914. doi: 10.1161/CIRCULATIONAHA.114.011320. Circulation. 2014. PMID: 25403596 Review. No abstract available.

8

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis.

Bellemain-Appaix A, Kerneis M, O'Connor SA, Silvain J, Cucherat M, Beygui F, Barthélémy O, Collet JP, Jacq L, Bernasconi F, Montalescot G; ACTION Study Group. Bellemain-Appaix A, et al. BMJ. 2014 Oct 24;349:g6269. doi: 10.1136/bmj.g6269. BMJ. 2014. PMID: 25954988 Free PMC article. Review.

9

Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD Study.

Barthélémy O, Cayla G, Silvain J, O'Connor SA, Bellemain-Appaix A, Beygui F, Sideris G, Varenne O, Collet JP, Vicaut E, Montalescot G; ABOARD Investigators. Barthélémy O, et al. Int J Cardiol. 2013 Sep 10;167(6):2646-52. doi: 10.1016/j.ijcard.2012.06.126. Epub 2012 Jul 12. Int J Cardiol. 2013. PMID: 22795712 Clinical Trial.

10

Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.

Montalescot G, Cayla G, Collet JP, Elhadad S, Beygui F, Le Breton H, Choussat R, Leclercq F, Silvain J, Duclos F, Aout M, Dubois-Randé JL, Barthélémy O, Ducrocq G, Bellemain-Appaix A, Payot L, Steg PG, Henry P, Spaulding C, Vicaut E; ABOARD Investigators. Montalescot G, et al. JAMA. 2009 Sep 2;302(9):947-54. doi: 10.1001/jama.2009.1267. JAMA. 2009. PMID: 19724041 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page